Theravance Biopharma, Inc. (TBPH) Debt Components
- 2024-12-31: Debt Instrument, Interest Rate, Effective Percentagepure 8.65%; Long-term DebtUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2023-12-31: Debt Instrument, Interest Rate, Effective Percentagepure (m); Long-term DebtUSD $0.00; Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2022-06-30: Debt Instrument, Interest Rate, Effective Percentagepure (m); Long-term DebtUSD $624.70M; Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2022-03-31: Debt Instrument, Interest Rate, Effective Percentagepure (m); Long-term DebtUSD $621.48M; Debt Instrument, Interest Rate, Stated Percentagepure (m).
Theravance Biopharma, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Interest Rate, Effective Percentage pure | Long-term Debt USD | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|---|---|
| 2024-12-31 | 8.65% | (m) | (m) |
| 2023-12-31 | (m) | $0.00 | (m) |
| 2022-06-30 | (m) | $624.70M | (m) |
| 2022-03-31 | (m) | $621.48M | (m) |
| 2021-12-31 | (m) | $616.33M | (m) |
| 2021-09-30 | (m) | $615.87M | (m) |
| 2021-06-30 | (m) | $609.51M | (m) |
| 2021-03-31 | (m) | $614.07M | (m) |
| 2020-12-31 | (m) | $619.17M | (m) |
| 2020-03-31 | (m) | (m) | 5.00% |
| 2019-12-31 | (m) | $455.04M | (m) |
| 2018-12-31 | (m) | $454.35M | (m) |
| 2017-12-31 | (m) | $223.75M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |